Showing results (1121-1130 of 1,205) with videos related to

Sort By:
Pageof 121
Nature Medicine|December 10, 2023
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trialLihua E Budde, Adam J Olszewski, Sarit Assouline, et al.
The New England Journal of Medicine|February 28, 2009
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North AmericaHenry M Wu, Brian H Harcourt, Cynthia P Hatcher, et al.
Blood|April 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 studyLihua E Budde, Manali Kamdar, Sarit E Assouline, et al.
Blood Advances|April 17, 2023
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphomaNancy L Bartlett, Sarit Assouline, Pratyush Giri, et al.
Haematologica|November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphomaMatthew J Maurer, Carla Casulo, Melissa C Larson, et al.
European Review for Medical and Pharmacological Sciences|March 18, 2022
Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative studyX Wang, X Wang, J Liu, et al.
Journal of the National Cancer Institute|June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinomaFergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
Plos One|June 24, 2025
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C Wei, Aaron J Cantor, Jack Walleshauser, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Pageof 121